Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
20.37
-0.03 (-0.15%)
At close: Aug 10, 2026, 4:00 PM EDT
20.30
-0.07 (-0.34%)
After-hours: Aug 10, 2026, 7:34 PM EDT

Syndax Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,8191,8361,1331,8331,7331,204
Market Cap Growth
63.81%62.10%-38.20%5.75%44.02%13.03%
Enterprise Value
1,8541,424552.031,2571,250777.72
Last Close Price
20.3721.0113.2221.6125.4521.89
PE Ratio
-----47.59
PS Ratio
7.2110.6547.84--8.61
PB Ratio
120.2728.413.933.313.712.95
P/TBV Ratio
118.4628.163.932.743.312.87
P/FCF Ratio
-----41.50
P/OCF Ratio
-----41.32
EV/Sales Ratio
7.358.2623.31--5.57
EV/EBITDA Ratio
-----29.61
EV/EBIT Ratio
-----29.66
EV/FCF Ratio
-----26.82
Debt / Equity Ratio
16.220.020.010.000.000.05
Debt / EBITDA Ratio
-----0.80
Debt / FCF Ratio
-----0.72
Net Debt / Equity Ratio
-20.46-6.38-2.02-1.04-1.03-1.04
Net Debt / EBITDA Ratio
1.591.511.712.513.19-16.21
Net Debt / FCF Ratio
1.401.272.113.593.62-14.68
Asset Turnover
0.410.270.04000.37
Inventory Turnover
0.320.424.51---
Quick Ratio
6.264.015.749.9416.7921.60
Current Ratio
6.774.405.8210.0016.8521.68
Return on Equity (ROE)
-553.79%-161.82%-75.69%-40.98%-34.10%7.55%
Return on Assets (ROA)
-31.49%-43.54%-50.78%-41.43%-32.05%6.99%
Return on Invested Capital (ROIC)
-742.36%-439.27%-437.47%-1123.37%-3190.85%877.95%
Return on Capital Employed (ROCE)
-38.31%-52.98%-57.76%-44.96%-33.83%7.38%
Earnings Yield
-----2.10%
FCF Yield
-----2.41%
Buyback Yield / Dilution
-1.95%-1.17%-21.67%-15.82%-13.31%-29.81%
Total Shareholder Return
-1.95%-1.17%-21.67%-15.82%-13.31%-29.81%
SEC Filings: 10-K · 10-Q